GI
DNA icon

GAMMA Investing’s Ginkgo Bioworks DNA Stock Holding History

GAMMA Investing’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Buy
1,038
+203
+24% +$1.7K ﹤0.01% 3192
2026
Q1 		$5.12K Buy
835
+312
+60% +$2.6K ﹤0.01% 3352
2025
Q4 		$4.35K Buy
523
+435
+494% +$4.68K ﹤0.01% 3346
2025
Q3 		$1.28K Buy
+88
New +$1.05K ﹤0.01% 3555
2025
Q1 		– Sell
-78
Closed -$766 – 3818
2024
Q4 		$766 Buy
78
+22
+39% +$189 ﹤0.01% 3489
2024
Q3 		$456 Buy
+56
New +$561 ﹤0.01% 3407
2024
Q2 		– Sell
-59
Closed -$2.76K – 3473
2024
Q1 		$2.76K Sell
59
-92
-61% -$4.76K ﹤0.01% 2642
2023
Q4 		$7.3K Buy
+151
New +$9.25K ﹤0.01% 2060

Other funds holding DNA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $689M AUM 16.24% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
HWA
HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

GAMMA Investing's DNA Position: Q2 2026 in Review

GAMMA Investing increased its Ginkgo Bioworks (DNA) stake by 24% in Q2 2026, buying an estimated $1.7K and bringing the position to 1,038 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

GAMMA Investing first reported a position in DNA in Q4 2023 and has held it in 8 quarters since. 10 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • GAMMA Investing held 1,038 shares of Ginkgo Bioworks worth $10.3K as of Q2 2026.
  • GAMMA Investing bought 203 Ginkgo Bioworks shares in Q2 2026, an estimated $1.7K.
  • Ginkgo Bioworks made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3192 holding.
  • GAMMA Investing first reported a position in Ginkgo Bioworks in Q4 2023 and has held it in 8 quarters since.
  • 10 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.